BSE Live
Jan 23, 16:01Prev. Close
458.10
Open Price
458.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:48Prev. Close
458.00
Open Price
460.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
440.25 (137)
| Balance Sheet of Thyrocare Technologies (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 52.84 | 52.79 | 53.72 | 53.69 | 53.72 | |
| Total Share Capital | 52.84 | 52.79 | 53.72 | 53.69 | 53.72 | |
| Reserves and Surplus | 310.07 | 378.44 | 389.57 | 354.12 | 311.89 | |
| Total Reserves and Surplus | 310.07 | 378.44 | 389.57 | 354.12 | 311.89 | |
| Total Shareholders Funds | 366.64 | 435.12 | 443.29 | 407.81 | 365.61 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 2.50 | 2.50 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 6.19 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 5.69 | 9.79 | 10.08 | 7.25 | 5.84 | |
| Long Term Provisions | 8.16 | 6.72 | 5.33 | 5.15 | 6.82 | |
| Total Non-Current Liabilities | 22.54 | 19.01 | 15.41 | 12.40 | 12.66 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 21.86 | 7.51 | 1.16 | 1.30 | 2.02 | |
| Other Current Liabilities | 58.83 | 11.61 | 17.99 | 15.33 | 10.40 | |
| Short Term Provisions | 1.01 | 1.47 | 1.14 | 0.99 | 18.98 | |
| Total Current Liabilities | 81.70 | 20.59 | 20.29 | 17.62 | 31.41 | |
| Total Capital And Liabilities | 470.88 | 474.72 | 478.99 | 437.83 | 409.67 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 167.65 | 185.78 | 190.18 | 151.17 | 151.36 | |
| Intangible Assets | 1.16 | 1.66 | 1.71 | 0.64 | 0.89 | |
| Capital Work-In-Progress | 4.93 | 1.47 | 0.00 | 17.45 | 1.02 | |
| Fixed Assets | 173.74 | 188.91 | 191.88 | 169.26 | 153.64 | |
| Non-Current Investments | 21.17 | 20.66 | 20.00 | 0.00 | 1.62 | |
| Deferred Tax Assets [Net] | 2.03 | 5.14 | 5.23 | 3.79 | 2.56 | |
| Long Term Loans And Advances | 4.26 | 4.19 | 1.54 | 0.63 | 10.60 | |
| Other Non-Current Assets | 17.15 | 12.94 | 11.08 | 7.76 | 0.00 | |
| Total Non-Current Assets | 318.63 | 338.70 | 336.59 | 288.30 | 275.27 | |
| CURRENT ASSETS | ||||||
| Current Investments | 69.03 | 74.64 | 100.10 | 104.16 | 91.63 | |
| Inventories | 20.62 | 18.08 | 17.05 | 14.50 | 10.72 | |
| Trade Receivables | 16.30 | 12.16 | 9.84 | 6.28 | 7.51 | |
| Cash And Cash Equivalents | 11.07 | 9.60 | 11.86 | 11.79 | 10.30 | |
| Short Term Loans And Advances | 0.66 | 0.07 | 0.02 | 6.98 | 7.70 | |
| OtherCurrentAssets | 34.57 | 21.47 | 3.53 | 5.83 | 6.56 | |
| Total Current Assets | 152.25 | 136.02 | 142.39 | 149.53 | 134.40 | |
| Total Assets | 470.88 | 474.72 | 478.99 | 437.83 | 409.67 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 234.87 | 320.01 | 0.00 | 0.00 | 405.20 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 36.74 | 36.74 | 37.38 | 37.38 | 37.38 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 20.00 | 0.00 | 1.62 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 69.03 | 74.64 | 0.00 | 0.00 | 93.75 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 100.10 | 104.16 | 0.00 |
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
24.10.2025
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss